1 results match your criteria: "Louisiana State University Health Sciences Center Department of Surgery[Affiliation]"

Background: In preclinical models, VEGF is a potent stimulant of both physiologic and pathologic angiogenesis. Conversely, anti-VEGF regimens have successfully inhibited angiogenesis both in vitro and in vivo. We hypothesized that VEGF would stimulate both physiologic and pathologic angiogenesis in a human-based fibrin-thrombin clot angiogenesis assay.

View Article and Find Full Text PDF